FindTrial
Sign In

Comparisons of efficacy, safety and recurrence risk factors of atrial fibrillation catheter ablation using robotic magnetic navigation system

Comparisons of efficacy, safety and recurrence risk factors of atrial fibrillation catheter ablation using robotic magnetic navigation system

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046505
Enrollment
Unknown
Registered
2021-05-18
Start date
2012-10-25
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Case series:atrial fibrillation catheter ablation using robotic magnetic navigation system

Sponsors

Wuxi People’s Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with drug-refractory symptomatic AF, more than one risk factor of thrombosis and no thrombus found by transoesophageal echocardiography examination in left atrium prior to ablation.

Exclusion criteria

Exclusion criteria: Patients with ages > 80 or = 55mm, contraindications to anticoagulation, severe hepatic, renal or lung dysfunction, hyperthyroidism, and thrombus in the left atrium illustrated on either echocardiography or CT scan.

Design outcomes

Primary

MeasureTime frame
efficacy, safety and recurrence risk factors;—

Countries

China

Contacts

Public ContactWang Ruxing

Wuxi People's Hospital Affiliated to Nanjing Medical University

ruxingw@aliyun.com+86 13358111992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026